Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
Radiation therapy is a cornerstone of modern cancer treatment, effectively targeting and destroying cancer cells in a specific area. However, its effects are not limited to the tumor alone; it can also impact the body’s immune system. For patients and their families exploring comprehensive cancer care options, a key question arises: how can we support the body’s natural defenses during and after radiation? This article explores the role of the immune system in cancer treatment and how Natural Killer (NK) cell therapy, an immunotherapy approach available in Japan, may serve as a complementary treatment to radiation.
Key Takeaways: Radiation and NK Cell Therapy
Radiation therapy is a powerful local treatment, but it can temporarily affect immune cells, including NK cells, which are crucial for fighting cancer. NK cell therapy is a type of immunotherapy that aims to bolster the immune system by using the patient’s own NK cells, which are cultured and activated outside the body before being returned via infusion. The concept of combining these two treatments is based on the potential for NK cell therapy to support the immune system, possibly complementing the effects of radiation. It is important to understand that this is an adjunctive therapy, not a replacement for standard treatments, and its suitability must be determined through a thorough medical consultation.
Understanding Radiation Therapy’s Dual Impact
Radiation therapy works by using high-energy rays to damage the DNA of cancer cells, leading to their death. This is highly effective at shrinking tumors and controlling local disease. While the primary goal is to target cancer cells, nearby healthy tissues and circulating immune cells can also be affected. Lymphocytes, a type of white blood cell that includes NK cells and T cells, are particularly sensitive to radiation. This can lead to a temporary decrease in their numbers, a condition known as lymphopenia. For patients, this raises concerns about potential side effects of radiation therapy and a weakened immune system, which could affect the body’s ability to fight off remaining cancer cells or new threats.
What is NK Cell Therapy?
Natural Killer (NK) cells are a vital part of the innate immune system, our body’s first line of defense. They are unique in their ability to patrol the body and eliminate abnormal cells, such as cancer cells or virus-infected cells, without prior sensitization. However, factors like age, stress, and the cancer itself can reduce the activity and number of NK cells. NK cell therapy is a medical procedure designed to counteract this. It involves drawing a sample of the patient’s blood, isolating the NK cells, and then activating and expanding them in a specialized facility. These enhanced NK cells are then returned to the patient’s body through an IV infusion, with the goal of strengthening the body’s immune surveillance capabilities.
Potential Synergy: How NK Cells May Complement Radiation
The combination of radiation and immunotherapy is an active area of clinical research. While radiation can reduce the number of immune cells, it can also, paradoxically, stimulate an anti-tumor immune response. When radiation destroys cancer cells, it can cause them to release tumor-specific antigens, which can act like signals that help the immune system recognize and target the cancer. This is where NK cell therapy may play a complementary role. By replenishing the pool of active immune cells, it could potentially help capitalize on this radiation-induced immune signal. The potential benefits of this combined approach are being explored from several angles:
- Supporting Immune Function: Administering activated NK cells may help offset the temporary decline in lymphocytes caused by radiation, thereby supporting overall immune function during a critical period.
- Targeting Weakened Cancer Cells: Cancer cells that survive the initial radiation dose may be weakened or stressed, potentially making them more vulnerable to attack by NK cells.
- Enhancing Systemic Response: While radiation is a local treatment, a strengthened immune system has the potential to act systemically, targeting cancer cells throughout the body.
It is crucial to note that research is ongoing, and the outcomes can vary significantly among individuals. This approach is considered an adjunctive cancer treatment, not a standalone cure.
Important Considerations Before Consultation
If you are considering NK cell therapy as a complement to radiation, it is essential to approach the decision with a clear understanding of several key points. First, NK cell therapy is not a substitute for standard cancer treatments like surgery, chemotherapy, or radiation therapy. It is intended to be used alongside them. Second, this therapy is provided as a treatment not covered by public health insurance (it is a private, out-of-pocket expense). In Japan, cell-based therapies like this are regulated under the Act on the Safety of Regenerative Medicine. This ensures that treatments are provided according to plans reviewed by certified committees and reported to the Ministry of Health, Labour and Welfare. Finally, eligibility, expected outcomes, potential risks, and side effects are highly dependent on your specific medical condition, cancer type, and overall health. A detailed consultation with a physician is necessary to determine if this therapy is a suitable option for you.
Exploring Your Options at Grand Green Osaka Umekita Clinic
For those in Japan or considering medical travel to Osaka, Grand Green Osaka Umekita Clinic offers consultations on cancer immune cell therapies, including NK cell therapy. Our team can provide detailed information and help you understand if this adjunctive treatment aligns with your overall cancer care plan. We believe in empowering patients with knowledge to make informed decisions in partnership with their healthcare providers. For more comprehensive information on the treatment process, costs, duration, and potential risks and side effects, please review our dedicated NK Cell Therapy page or schedule a consultation.
→ Learn more about NK Cell Therapy at our clinic.
Conclusion: A Holistic Approach to Cancer Care
Combining radiation therapy with immunotherapy like NK cell therapy represents a forward-thinking approach to cancer treatment, focusing on both eliminating the tumor and supporting the body’s own defense mechanisms. While radiation delivers a powerful, localized attack, NK cell therapy aims to reinforce the systemic immune response. This potential synergy offers a promising avenue for complementing standard cancer care. However, any decision regarding treatment must be made after a careful and personalized assessment by a medical professional. Discussing all available options with your doctor is the most important step in creating a comprehensive treatment strategy tailored to your unique situation.
Radiation Therapy
- Powerful local treatment
- Can temporarily reduce immune cells
- May signal the immune system
NK Cell Therapy
- Aims to boost immunity
- Replenishes active immune cells
- Potential for systemic effect
This is a conceptual diagram to summarize the main points of the article
References
- PubMed: Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives. (2025)
- PubMed: Molecular features of TNBC govern heterogeneity in the response to radiation and autophagy inhibition. (2025)
- PubMed: Robo1 CAR-NK92 and radiotherapy exert synergistic efficacy in solid tumors. (2025)
- PubMed: Anti-GD2 immunotherapy for neuroblastoma. (2017)
- PubMed: Impact of IL-12 in Cancer. (2017)
- PMC: Radiotherapy and immunotherapy in cancer treatment: mechanisms of clinical synergy. (2026)
- PMC: Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment. (2022)
- PMC: Challenges in the combination of radiotherapy and immunotherapy for breast cancer. (2023)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.